30.06.2025 • News
IMCD Acquires Chilean Specialty Chemicals Distributor
IMCD has acquired Apus Química, a specialty chemicals distributor in Chile.
Mergers & Acquisitions (M&A)
Sika Acquires Gulf Additive Factory
Sika has acquired Gulf Additive Factory in the State of Qatar. The company manufactures a wide range of construction chemical products.
AkzoNobel to Sell AkzoNobel India to JSW Group
AkzoNobel has signed an agreement to sell its shareholding in AkzoNobel to the JSW Group, one of India’s leading diversified conglomerates.
IMCD Acquires Indian Pharma Supplier Trichem
IMCD, a global partner for the distribution and formulation of speciality chemicals and ingredients, has acquired Trichem, an Indian pharmaceutical supplier.
12.06.2025 • News
Aditya Birla Acquires Cargill Specialty Chemicals Facility
Aditya Birla, an Indian multinational conglomerate, recently announced the expansion of its US Advanced Materials business with the acquisition of Cargill’s specialty chemical facility in Dalton, Georgia.
Brenntag Specialties Acquires Mcepharma
Brenntag recently announced the acquisition of Mcepharma to strengthen Brenntag’s capabilities across the entire pharmaceutical and biopharmaceutical value chain.
Dow Sells its 50% Ownership in DowAksa
Dow announced that it has signed a sale and purchase agreement to sell its 50% interest in DowAksa to Aksa Akrilik Kimya Sanayii A.Ş., a company of Akkök Holding.
Sanofi to Acquire Blueprint Medicines
Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology.
02.06.2025 • News
BASF to Acquire Shares in Alsachimie
BASF and DOMO Chemicals have signed an agreement giving BASF the right to acquire DOMO Chemicals' 49% stake in the Alsachimie joint venture, in which BASF currently holds 51%.
Sanofi to Acquire Vigil Neuroscience
Sanofi to acquire Vigil Neuroscience, a clinical-stage biotech focused on therapies for neurodegenerative diseases.
Honeywell to Acquire Johnson Matthey's Catalyst Technologies Business
Honeywell will acquire Johnson Matthey's Catalyst Technologies business segment for €2.15 billion in an all-cash transaction.
19.05.2025 • News
IMCD to Acquire Tecom Ingredients
IMCD has signed an agreement to acquire 100% of the shares in Tecom Ingredients.
16.05.2025 • News
Sojitz Acquires Majority Shares in Nippon A&L
Sojitz, Sumitomo Chemical, and Mitsui Chemicals have concluded a share purchase agreement in which Sojitz will acquire Nippon A&L.
PCI Pharma Services Acquires Ajinomoto Althea
PCI Pharma Services has completed its acquisition of Ajinomoto Althea, a CDMO subsidiary of Ajinomoto.
Roquette Acquires IFF Pharma, Reorganizes into Two Business Groups
Roquette completes IFF Pharma Solutions acquisition and unveils new structure for global growth and innovation.
28.04.2025 • News
Merck to Acquire US Biopharma Company SpringWorks Therapeutics
Merck and biopharmaceutical company SpringWorks Therapeutics, have entered into a definitive agreement for Merck to acquire SpringWorks.
10.04.2025 • News
Strategic Value Partners and Blantyre Capital Acquire OQ Chemicals
Strategic Value Partners (SVP) and Blantyre Capital Limited (Blantyre) recently announced the acquisition of OQ Chemicals (Oxea), a leading global producer and merchant of oxo chemicals.
03.04.2025 • News
HAS Acquires Cerbios-Pharma
HAS Healthcare Advanced Synthesis (HAS) recently announced the planned acquisition of Cerbios-Pharma (Cerbios), a globally recognized manufacturer of chemical and biological APIs, including antibody-drug conjugates (ADCs).
Ineos Energy Acquires Oil & Gas Assets from CNOOC
The completion of the deal marks the third major investment by Ineos Energy in the USA in the past three years. It increases Ineos' capital spending on energy assets in the USA to above $3 billion.
11.03.2025 • News
Sun Pharma to Acquire Checkpoint Therapeutics
Indian generic drug maker Sun Pharma agreed to acquire US immunotherapy and targeted oncology company Checkpoint Therapeutics for an upfront value of $355 million. The transaction is expected to be completed in the second quarter of 2025 and is subject to customary closing conditions.
07.03.2025 • News
Rio Tinto Completes Acquisition of Arcadium Lithium
Rio Tinto has completed the $6.7 billion acquisition of Arcadium Lithium and is now the parent company of Arcadium Lithium, which will be renamed Rio Tinto Lithium and will also include the Rincon Lithium Project.
07.03.2025 • News
Jazz Pharmaceuticals to Acquire Chimerix for $935 Million
Ireland’s Jazz Pharmaceuticals signed an agreement to acquire its compatriot Chimerix for approximately $935 million. The transaction is expected to close in the second quarter of 2025.
06.03.2025 • News
ADNOC and OMV to Create Global Polyolefins Group
OMV and ADNOC agreed to combine their Borealis and Borouge shareholdings into Borouge Group International. ADNOC has also signed a share purchase agreement with Nova Chemicals, an indirect wholly owned subsidiary of Mubadala Investment Company, to acquire 100% of Nova Chemicals for an enterprise value of $13.4 billion. In addition, ADNOC and OMV have agreed for Borouge Group International to take over Nova Chemicals after closing.
04.03.2025 • News
WE Soda Buys Soda Ash Producer Genesis Alkali
WE Soda has acquired Genesis Alkali (Alkali), the largest US-based producer of natural soda ash, from Genesis Energy in an all-cash transaction for $1.425 billion.
26.02.2025 • News
Granules India Buys Swiss CDMO Senn Chemicals
Indian pharmaceutical company Granules India has agreed to acquire Senn Chemicals, a Swiss-based contract development and manufacturing organization (CDMO) specializing in peptides. The closing of the deal, which is subject to certain conditions, is expected to occur in the first half of 2025. Financial details of the transaction were not disclosed.
21.02.2025 • News
Pritzker Private Capital Acquires Majority Stake in Americhem
US investment company Pritzker Private Capital (PPC) has agreed to acquire a majority stake in Americhem, a family-owned US manufacturer of custom color masterbatch, performance additive and engineered compound solutions.
21.02.2025 • News
FibroGen Sells Chinese Subsidiary to AstraZeneca
US-based biotechnology company FibroGen announced the sale of its China subsidiary to AstraZeneca for approximately $160 million.
20.02.2025 • News
Sanofi and CD&R Sign Share Purchase Agreement for Opella
Following completion of the required social and corporate procedures, Sanofi and CD&R have signed the share purchase agreement for the sale of a 50% controlling stake in its consumer health business Opella to US private equity firm Clayton Dubilier & Rice (CD&R).
12.02.2025 • News
Novonesis Acquires Feed Enzyme Alliance Share from DSM-Firmenich
Novonesis has reached an agreement with its partner DSM-Firmenich to dissolve the Feed Enzyme Alliance and take over its sales and distribution activities, for a total cash payment of €1.5 billion. The transaction is subject to customary closing conditions.
11.02.2025 • News
Novartis to Acquire Anthos Therapeutics
Swiss drugmaker Novartis has agreed to acquire Anthos Therapeutics, a Boston, US-based biopharmaceutical company with its lead compound abelacimab, a late-stage medicine in development for the prevention of stroke and systemic embolism in patients with atrial fibrillation.
10.02.2025 • News
Bain to Acquire Mitsubishi Tanabe Pharma for $3.3 Billion
US private equity company Bain Capital has agreed to acquire Mitsubishi Tanabe Pharma Corp. (MTPC) from Mitsubishi Chemical Group Corp. in a deal that values the business at approximately 510 billion Japanese yen ($3.3 billion).
06.02.2025 • News
Jabil Acquires CDMO Pharmaceutics International
Jabil, a global provider of engineering, manufacturing, and supply chain solutions, has acquired Pharmaceutics International (Pii), a US contract development and manufacturing organization (CDMO) specializing in early-stage, clinical, and commercial volume aseptic filling, lyophilization, and oral solid dose manufacturing. Financial details of the transaction, which was completed on Feb. 3, 2025, were not given.
29.01.2025 • News
Sage Therapeutics Rejects Biogen’s Takeover Offer
Sage Therapeutics announced that its board of directors has unanimously rejected the proposal it received from Biogen on Jan. 10, 2025, to acquire all outstanding shares of Sage not already owned by Biogen for $7.22 per share, representing an equity value of about $469 million.
22.01.2025 • News
Johnson & Johnson to Acquire Intra-Cellular Therapies
Johnson & Johnson and Intra-Cellular Therapies recently entered into a definitive agreement under which Johnson & Johnson will acquire all outstanding shares of Intra-Cellular Therapies, a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders.
21.01.2025 • News
Grupa Azoty Nears Sale of Polyolefins Business to Orlen
Grupa Azoty and Orlen have agreed to continue to work on the terms of a potential transaction whereby Orlen – or another entity designated by Orlen – would acquire all or a portion of the shares currently held by Grupa Azoty in Grupa Azoty Polyolefins or otherwise execute the investment.
Bristol-Myers Squibb
Deloitte
LANXESS Deutschland GmbH
Novartis International AG
Proventis Partners
Merck KGaA
Zeta GmbH
PPG
Novo Nordisk A/S
Jazz Pharmaceuticals, plc
Universität Hohenheim - Institut für Lebensmitteltechnik
Frost & Sullivan
AstraZeneca
CABB AG
H.B. Fuller Company
A.T. Kearney GmbH
Barentz
Accenture
Gilead Sciences GmbH
The Dow Chemical Company
AkzoNobel
Olon S.p.A.
Sanofi S.A.
CHEManager c/o Wiley-VCH Verlag GmbH & Co. KGaA
Rhodia Europe
Henkel AG & Co. KGaA
Camelot Management Consultants AG
Merck & Co
Lincoln International
The Valence Group
EuroAPI
Deutsche Post DHL
Managm. Consult. Chemicals
Perstorp Holding AB
Infraserv GmbH & Co. Höchst KG
DistriConsult GmbH
SchüllerConsulting
ICIG
Royal DSM N.V.
Lonza AG
Trinseo LLC
Medera
Bachem
Squire Patton Boggs
Azelis Corporate Services NV
Ineos
Arkema
Booz & Company
EvaluatePharma
HAS Healthcare Advanced Synthesis SA